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INTRODUCTION  
Induction of labour can be defined as an intervention intended to 
artificially initiate uterine contractions resulting in progressive effacement 
and dilation of cervix. This should ideally result in the birth of the baby 
through vaginal route. 
The more common indications include post term pregnancy, 
membrane rupture without labour, gestational hypertension, 
oligohydramnios, non reassuring fetal status  and various maternal medical 
conditions such as chronic hypertension and diabetes (American College 
of Obstetricians and Gynaecologists, 2013b). Before induction one must 
ensure that the gestational age and fetal lung maturity is confirmed.  
Induction of labour is one of the most common interventions 
practiced in modern world. Overall throughout the world, up to 20 per cent 
of women have labour induced by one method or the other. Induction rates 
vary with practices and cultural backgrounds. The availability of newer 
oxytocics and induction techniques which are safer, more effective and 
predictable than the older techniques has made the process of induction 
more easier.  
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AIM OF THE STUDY  
1. To evaluate the influence of vaginal pH on the efficacy of PGE2 gel 
for cervical ripening/labour induction 
2. To improve patient selection for PGE2 induction and reduce the 
incidence of failed induction with PGE2 gel. 
3. To asses the labour outcome in induction with PGE2 by knowing 
the vaginal pH prior induction. 
4. To asses whether vaginal pH itself has a significant effect on the 
Bishop score prior induction or not. 
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MATERIALS AND METHODS 
METHODOLOGY  
The Prospective study was conducted in Govt. RSRM Lying In 
Hospital, Chennai during the period of December 2016 to September 2017 
after getting approval from the Institutional Ethical Committee. 
100 patients who underwent induction of labour for various reasons 
were selected for the study and examined.  
Before other examinations were performed, each participant 
underwent a speculum examination and vaginal pH value was assessed 
by using pH indicator paper (both broad & narrow spectrum). 
The indicator paper was placed on the lateral vaginal wall between 
the two valves of Cusco’s speculum until it became wet. 
Colour change of the strip was immediately compared with the 
manufacturer’s colorimetric scale and the finding was recorded. 
A vaginal examination was then performed to determine the 
Bishop’s score.  
Bishop score was assessed 
Cervical dilatation, cervical effacement/length, Cervical 
consistency, Cervical position, Fetal station. Each component is given a 
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score of 0-2 or 0-3. The highest possible score is 13 and <5 is 
unfavourable that needs induction. All received intracervically placed 
PGE2 gel 0.5 mg  
After ruling out all contraindications, All received intracervically 
placed PGE2 gel 0.5 mg . Following application the patient is instructed to 
remain recumbent for at least 30 minutes. The patient is then continuously 
monitored. 
After 6 hrs depending on Bishop Score and uterine contraction 
either PGE2 gel was repeated (maximum 2 doses) or labour was 
augmented as per labour theatre protocol.  
The differences between the groups with respect to age, parity, 
Bishop score prior induction, need for a second induction, time to enter 
into active phase of labour and the final mode of delivery were compared 
and analysed. The induction delivery interval, Caesarean section rates and 
indications, Birth weight and APGAR score of the babies were noted and 
tabulated. Statistical analysis was done and P value <0.05 was considered 
significant. 
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Inclusion criteria  
(1)  An unfavourable cervical Bishop score of ≤ 5, 
(2)  Singleton pregnancy with vertex presentation and no 
contraindication to vaginal delivery. 
 (3)  Assuring fetal heart rate. 
Exclusion criteria  
(1)  Known hypersensitivity to prostaglandins  
(2)  Placenta previa  
(3)  Suspected chorioamnionitis 
(4)  Parity of >3  
(5)  A previous caesarean delivery or a history of uterine surgery 
(6)  Previous attempted induction of labour for this pregnancy 
(7) Cephalopelvic disproportion. 
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REVIEW OF LITERATURE  
INDUCTION OF LABOUR   
  Induction of labour is the initiation of contractions in a pregnant 
woman who is not in labour to help her achieve a vaginal birth within 24 
to 48 hours.  
Successful induction is defined as a vaginal delivery within 24 to 48 
hours of induction of labour.  
Elective induction is the induction of labour in the absence of 
acceptable fetal or maternal indications.  
Cervical ripening is the use of pharmacological or other means to 
soften, efface, or dilate the cervix to increase the likelihood of a vaginal 
delivery.   
PATIENT PREREQUISITE FOR INDUCTION   
Assessment of maternal parameters   
• Confirm the indication for induction   
• Review for contraindication to labour and/or vaginal delivery    
• Assess the shape and adequacy of bony pelvis   
• Assess the cervical status by Bishop score   
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• Review risk and benefit of induction of labour with patient and 
the family   
Assessment of fetal parameters   
• Confirm the gestational age   
• Estimate fetal weight   
• Determine fetal position   
• Determine fetal well being   
INDICATIONS OF INDUCTION  
OBSTETRIC INDICATIONS :   
• Post term pregnancy   
• Preeclampsia, eclampsia    
• Previous unexplained IUD   
• Fetal compromise (eg,Fetal growth restriction, isoimmunization)   
• Preterm  Premature rupture of membranes (PPROM)  
• Prelabour rupture of membranes(PROM)  
• Malformed fetus   
• Severe  hydraminos   
• Oligo hydraminos   
• Gestational diabetes mellitus   
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• Abruptio placentae   
• Chorioamnionitis   
• Fetal demise   
• Cholestasis of pregnancy  
MATERNAL MEDICAL CONDITIONS AGGRAVATED BY 
PREGNANCY :  
• Diabetes mellitus   
• Chronic  renal disease  
• Chronic pulmonary disease    
• Chronic hypertension   
CONTRAINDICATIONS ABSOLUTE  
• Active genital herpes infection   
• Serious chronic medical condition   
• Pelvic Structural abnormality   
• Cephalopelvic disproportion major degree   
• Abnormal fetal lie [transverse lie, oblique lie]   
• Umbilical cord prolapse   and cord presentation  
• Placenta previa of major degree and vasa previa   
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• Previous classical Caesarean section or other transfundal uterine 
surgery.   
• Previous Myomectomy entering the endometrial cavity.  
• Contraindication specific to the inducing drug used.   
• Invasive cervical cancer.  
RELATIVE   
• Uterine overdistension [multiple pregnancy, polyhydraminos]   
• Breech   
• Fetal macrosomia   
• Low lying placenta   
• Abnormal fetal heart pattern  
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METHODS OF LABOUR INDUCTION 
I-NON PHARMACOLOGIC METHODS  NATURAL METHODS  
• Relaxation techniques   
• Sexual intercourse   
• Nipple stimulation   
• Hot Bath / Castor oil / Enemas   
• Cumin Tea   
• Several herbs   
• Acupressure   
• Acupuncture  
MECHANICAL METHODS   
• Osmotic dilators Laminaria and Dilapan  
• Balloon devices Foleys . 
SURGICAL METHODS  
• Stripping the membranes  
• Amniotomy  
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II- PHARMACOLOGICAL METHODS   
• Oxytocin   
• Prostaglandins  
 Misoprostol [ E1]  
 Dinoprostone [E2]    
• Mifepristone     
COMPLICATIONS OF INDUCTION  
MATERNAL  
 Uterine tachysystole 
 Uterine Rupture  
 Failed Induction and Increased Caesarean Delivery Rate  
 Sepsis  
 Postpartum Haemorrhage  
 Accidental Haemorrhage  
 Amniotic Fluid Embolism  
FETAL  
 Iatrogenic prematurity  
 Umbilical Cord Prolapse    
 Hyperbilirubinemia  
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INDUCTION OF LABOUR 
Induction of labour is defined as the process of artificially 
stimulating the labour.  It is usually performed by administering oxytocin 
or prostaglandins to the pregnant woman or by manually rupturing the 
amniotic membranes. This should ideally result in the delivery of the baby 
through the vaginal route (RCOG 2001). Ideally, most pregnancies should 
be allowed to reach term, the onset of spontaneous labour being the sign of 
physiologic termination of pregnancy. It is one of the most common 
interventions practiced in modern obstetrics. Overall, throughout the 
world, up to 20 per cent of women have labour induced by one method or 
the other. Induction rates vary with practices and cultural  backgrounds. 
Cervical ripening greatly facilitates labour and augments the chances  of 
vaginal birth. The cervical state is related to the success of labour 
induction, duration of labour, and likelihood of vaginal delivery.    
Elective inductions for the convenience of either the obstetrician or 
the patient are on the rise. Due to the attendant risk of severe, though 
infrequent, adverse maternal outcomes, elective inductions are not 
routinely recommended.   
Recent opinions, however, tend to veer towards the idea that 
elective inductions before 41 weeks may not be as bad as obstetricians 
have traditionally believed  (Macones 2009).   
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HISTORY OF INDUCTION OF LABOUR 
Since antiquity various methods, many bizarre and some frankly 
dangerous, have been used in an attempt to bring on labour. Massage of 
the breasts and uterus are very old but inefficient methods. Something 
approaching the use of tents dates back to the sixth century, and stretching 
of the cervix digitally has been long employed. The last century brought 
with it more ingenuity and at one time electricity was thought of. Scanzoni 
used a hot carbolic acid douche in 1856, and at  this time Kraus introduced 
his bougies, which fell into disuse by the 1930s because of their relative 
inefficiency, high sepsis rate and the often countered risk of harpooning or 
detaching the placenta.   
Artificial rupture of the membranes stands in a class by itself, for it 
has stood a prolonged test of time, being first used by Denman in 1756 for 
cases of contracted pelvis, and being known since then as the “English 
method”. It remains to this day a widely used method in spite of the 
sacrifice of an intact amniotic sac that it entails. Hind water rupture with 
Drew Smythe catheter was introduced in 1931, but what it gains in safety, 
in terms of fore water preservation with reduced risk of amniotic fluid 
infection and cord prolapse, it loses in efficiency when compared with fore 
water rupture.   
Prostaglandin was first isolated from seminal fluid of monkeys, 
sheep and goat, by Ulf von Euler at the Karolinska Institute in Stockholm 
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in 1935. It was believed to be part of prostatic secretions and was therefore 
called prostaglandin.   
Elias Corey synthesized dinoprostone in 1970 at the Harvard 
University. Three biochemists, Bergstrom, Samuelsson and Vane jointly 
received the 1982 Nobel Prize for their discovery of prostaglandins.   
The reasons for the rising rates of induction of labour can be 
complex and multifactorial (Rayburn and Zhang 2002).    
Some of them are: -   
• Improved ability of physicians to determine gestational age 
accurately with early dating scans, thus avoiding the possibility of 
iatrogenic prematurity.   
• Widespread availability of cervical ripening agents.  
• Improved knowledge of methods and indications for induction.   
• More relaxed attitudes towards marginal/elective indications, both 
of the physician and the patient.   
• Litigation constraints.    
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GENERAL PRINCIPLES RELATED TO INDUCTION 
• The  Induction of labour should be performed only when there is a 
clear medical indication for it and the expected benefits outweigh its 
potential harms.  
• Induction of labour should be performed with caution since the 
procedure carries the risk of uterine hyperstimulation and rupture 
and fetal distress.  
• Induction of labour is carried out, facilities should be available for 
assessing maternal and fetal well-being.  
• Women receiving oxytocin, misoprostol or other prostaglandins 
should never be left unattended. 
• Failed induction of labour does not necessarily indicate caesarean 
section. 
•  Wherever possible, induction of labour should be carried out in 
facilities where caesarean section can be performed.  
Criteria of an ideal inducing agent   
An ideal inducing agent is one which:   
• Achieves onset of labour within the shortest possible time.   
• Should not  result in greater pain . 
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• Has low failure rate. 
• Does not increase the rate of caesarean delivery or operative vaginal 
deliveries as  compared to spontaneous labour.   
• There should be a less perinatal morbidity.  
We are yet to find an ideal inducing agent. Hence, the decision for 
induction should be well thought out and communicated to the woman 
concerned.   
PRE INDUCTION COUNSELLING FOR THE COUPLE  
It is essential to have good communication with the woman and 
her family prior to induction; wherever possible this should be supported 
by evidence-based and preferably, written information. During induction 
of labour, the woman has restricted mobility and the procedure itself can 
cause discomfort to her. To avoid potential risks associated with the 
procedure, the woman and her baby need to be monitored closely. 
According to  (RCOG 2008):   
- Explain the indications for induction; more specifically, the 
consequences associated with continuing the pregnancy   
- Explain the time and procedure of induction   
- Arrangements for support during labour   
- Pain relief measures should be taken 
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- The need for close monitoring of the fetal heart rate (including 
electronic fetal monitoring in labour)   
- Should give multiple options. 
- The risks associated inducing agent used.   
- The chances of failure of induction and the options available in case 
of failure.   
In summary, the woman and her partner should be offered to be 
made a part of the decision-making process. A positive attitude imparted 
to the woman when she is actively involved in the decision making, not 
only increases the chances of success of induction but also enables her to 
better face the consequences (Nuutila  et al  1999).   
WOMEN’S ATTITUDE TOWARDS INDUCTION   
One study showed that 76 per cent of women following an induction 
prefer not to be induced in the next pregnancy (Cartwright 1977). More 
recent studies show a better response. Roberts and Yound (1991) found 
that when perception after the event was compared with anxieties of 
continuing the pregnancy beyond term in uncomplicated pregnancies, 
more women opted for elective induction than conservative management. 
They also said that most pregnant women are unwilling to accept the 
conservative management of prolonged pregnancy and more so if 
undelivered by 41 weeks gestation. Women today would not prefer 
conservative management of pregnancy beyond term.  
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INDICATIONS AND CONTRAINDICATIONS FOR INDUCTION   
The indications can be divided under the following headings:   
1. Obstetrical conditions;   
2. Medical conditions aggravated by pregnancy.   
The correct selection of cases in itself predisposes certainty as to the 
child’s maturity. The best paediatric unit in the world is no substitute for a 
healthy intrauterine environment up to the time of adequate maturity and 
there is now no excuse for being in doubt about this, thanks to the 
precision afforded by modern sonar techniques.   
COMMONLY ACCEPTED INDICATIONS FOR INDUCTION OF  
LABOUR   
- Pregnancy-induced hypertension   
- Premature rupture of membranes   
- Severe intrauterine growth restriction   
- Rhesus Iso immunization   
- Maternal medical problems (diabetes mellitus, lupus, renal disease)   
- Intrauterine fetal demise   
- Postdated pregnancy   
- Oligohydramnios   
- Logistic factors ( distance from hospital)    
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OBSTETRIC INDICATIONS   
INDUCTION OF LABOUR IN WOMEN AT OR BEYOND TERM 
Pregnancies that reach beyond 42 gestational weeks are defined as 
post-term. This is the commonest indication for induction of labour 
worldwide. 
Evidence related to induction of labour at term and beyond term was 
extracted from one Cochrane systematic review of 22 randomized 
controlled trials (10). Most of the trials were judged by the Cochrane 
review authors to likely have a moderate risk of bias, largely due to 
unclear concealment of allocation and generation of the sequence of 
randomization.  
The trials had evaluated the effect of inducing labour at 37–40 
weeks, 41 completed weeks, and 42 completed weeks of gestation, and the 
intervention was compared with expectant management with fetal 
monitoring at varying intervals. There were no statistical and clinical 
differences in the priority comparisons and outcomes, except for a 
reduction in perinatal deaths when labour was induced at 41 completed 
weeks.  
 
 
  
20 
Recommendations  
Induction of labour is recommended for women who are known 
with certainty to have reached 41 weeks (> 40 weeks + 7 days) of 
gestation. (Low-quality evidence. Weak recommendation.)  
Induction of labour is not recommended for women with an 
uncomplicated pregnancy at gestational age less than 41 weeks. (Low-
quality evidence. Weak recommendation.)  
A recent systematic review (Caughey et al 2009) showed that 
women who completed 41 weeks of gestation or more who were managed 
expectantly had a higher risk of caesarean section. It also suggested that 
elective induction of labour at 41 weeks of gestation and beyond is 
associated with a decreased risk of caesarean section and meconium 
staining of the amniotic fluid. Fetal monitoring should begin at 41 weeks 
of gestation. In their study of expectant management versus induction of 
labour in post-term pregnancies, James et al (2001) found that 57 per cent 
of women went into spontaneous labour by 41 weeks and 4 days (291 
days) of gestation and only 14 per cent developed fetal compromise before 
that. However, when the gestational age was more than this period, the 
incidence of meconium stained amniotic fluid and evidence of 
uteroplacental insufficiency was increased significantly. There was no 
significant difference in the rate of caesarean section, instrumental 
delivery, fetal distress and duration of labour between the two groups.  The 
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American College of Obstetricians and Gynaecologists recommends that 
women who are post-term and also have unfavourable cervices can either 
undergo labour induction or be allowed to be managed expectantly. Many 
studies recommend prompt delivery in an uncomplicated post-term patient 
with a favourable cervix (ACOG 2004). The Department of Obstetrics and 
Gynaecology and Reproductive Biology at Harvard Medical School 
recommends routine induction at 41 weeks gestation (Rand et al 2000).    
INTRAUTERINE GROWTH RESTRICTION   
Chronic placental insufficiency leads to intrauterine growth 
restriction. Infants with growth restriction have a higher risk of perinatal 
morbidity and mortality, which usually results from placental 
insufficiency. The placental insufficiency is likely to be aggravated by 
labour. Due to low placental reserve as compared to normal fetus, these 
fetuses, as a group, might require induction of labour prior to their 
expected date of delivery. 
PRE-ECLAMPSIA AND ECLAMPSIA   
The more severe pre-eclampsia is, the greater risk of serious 
complications to both mother and baby. The exact cause of cause of pre-
eclampsia is uncertain but it is thought to be due to a problem with the 
placenta. Hence delivering the baby is the only way to cure pre-eclampsia 
and eclampsia. 
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PREVIOUS UNEXPLAINED INTRAUTERINE FETAL DEATH  
  This peculiar entity, said to be due to placental insufficiency may, 
by the warning history, provide an opportunity to forestall disaster by 
timely induction which is usually done at 38 weeks, but may be done 
earlier if indicated by fetal monitoring tests.   
PRELABOUR RUPTURE OF MEMBRANES    
(PROM) at term complicates about 8-10% pregnancies. It has been 
a matter of great controversy whether women with term PROM should be 
induced or managed with an expectant policy, and if the latter course is 
opted, how long is it safe to await spontaneous labour. Results from many 
randomized trial to date demonstrate that expectant management was 
associated with an increased incidence of clinical chorioamnionitis, 
postpartum fever, longer hospital stay for the mother and a long stay for 
the baby in the neonatal intensive care unit; induction therefore seems to 
be a reasonable choice.   
RH ISO-IMMUNISATION   
In moderately or severely affected cases, where pregnancy has 
already reached the 34th week, induction of labour and delivery of the 
child in spite of prematurity is safer and more likely to be successful than 
intrauterine transfusion. The object of the induction is to get the child 
delivered so that it is available for exchange transfusion after birth and the 
timing will depend upon the likely severity of the disease.     
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MALFORMED FETUSES   
The prolongation of pregnancy is profitless, and on grounds of 
humanity as well, pregnancy is better terminated. Besides it is better to 
deliver a small monster than a large one. 
HYDRAMNIOS  
Severe hydramnios producing marked pressure symptoms may call 
for relief. There is the danger of accidental haemorrhage following 
artificial rupture of the membranes in these cases.    
ABRUPTIO PLACENTA  
Minor degrees of placental abruption without any signs of fetal 
distress are best managed by amniotomy and oxytocin infusion.   
INTRAUTERINE DEATH OF THE FETUS.   
Spontaneous labour will always start eventually, but the patient can 
often be spared some very wretched weeks of waiting if labour is induced. 
Drug induction is both safe and usually efficacious.   
MEDICAL INDICATIONS  
CHRONIC RENAL DISEASE. 
Pregnancy has no known beneficial effects whatever on the healthy 
kidney, and where renal function is already damaged the effects of 
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pregnancy vary between bad and disastrous. The decision and the timing 
of intervention must be taken considering both maternal and fetal interests.   
HYPERTENSION   
The risks of fetal prematurity have to be weighed against the risk of 
superimposed pre-eclampsia and abruption placenta.   
DIABETES   
Whether or not pre-eclampsia is added to this complication, 
induction of labour is often called for to forestall intrauterine fetal death, 
which is a very real risk in the third trimester, particularly in the 
uncontrolled diabetics and those associated with hypertension.    
CONTRAINDICATIONS TO LABOUR INDUCTION    
- Placenta or vasa previa   
- Fetal malpresentations   
- Prior classic uterine incision   
- Active genital herpes infection or any other lower genital tract 
infections and tumors.   
- Pelvic structural deformities and major degree cephalopelvic 
disproportions.   
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Disproportion that is more than borderline. It must have been made 
abundantly clear already that such treatment is little short of wanton folly 
rewarded with a high failure rate, a prohibitive fetal mortality and the 
likelihood of maternal morbidity.   
1. Where the lie is other than longitudinal, for obvious reasons.   
2. In cases of previous caesarean section for contracted pelvis or who 
have failed in previous trial of labour for disproportion. However, it 
may be added that a pelvic examination must be done to confirm the 
presence of cephalopelvic disproportion, as some of these cases may 
have been mistakenly labeled or in some cases the baby may be 
smaller than it was in the previous pregnancy.   
3. Where a tumour occupies the pelvis.   
4. When vaginal delivery is contraindicated. These include major 
degree placenta previa, vasa previa, cord presentation and 
prolapsed, invasive carcinoma cervix, and infections like active 
herpes genitalis and HIV.   
5. Previous classical caesarean section. Some conditions which are 
considered to be relative contraindications include maternal heart 
disease, multiple pregnancy, borderline clinical pelvimetry, grand 
multiparity, non-reassuring fetal testing not requiring emergency 
delivery.   
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Though not a contraindication, extreme caution is required in grand 
multipara because of the tumultuous precipitate labour that can follow, and 
cases of previous caesarean section or myomectomy because of the danger 
of uterine rupture.    
PREINDUCTION CERVICAL RIPENING   
Starting with a favourable cervix ensures the success of labour 
induction. Further, the time taken of labour induction is affected by parity 
and to a small degree by baseline uterine activity and sensitivity to 
oxytocic drugs. The goal of cervical ripening is to facilitate the process of 
cervical softening, effacement and dilatation, thus reducing the induction 
to-delivery time. When there is an indication for induction and the cervix 
is unfavourable, agents for cervical ripening may be used.    
Cervical ripening is the process that culminates in the softening and 
distensibility of the cervix, which facilitates labour and delivery. The 
cervix contains relatively few smooth muscle cells and derives its rigidity 
from collagen bundles surrounded by proteoglycans. In pregnancy nearing 
term, there are various factors that induce certain changes in the cervix 
leading to cervical ripening. There are agents that can artificially induce 
these changes if it has not occurred. It is difficult to separate methods of 
cervical ripening and labour induction 
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Cervical ripening is associated with the disorganization of collagen 
bundles which is likely to be effected by collagenase. The active area of 
cervical tissue remodelling is at the internal OS. The collagenase found in 
the cervix has been identified as neutrophil derived and the invading 
neutrophil plays an important role in the tissue rearrangements associated 
with cervical ripening. 
Neutrophils represent a readily available source of collagenase, 
present in specific granules, which can be made available by degranulation 
rearrangement of extracellular matrix. 
Another change is an increase in cervical decorin (dermatan sulfate 
proteoglycan 2), leading to collagen fiber separation.  
These changes together lead to softening of the cervix. As uterine 
contractions ensue, the ripened cervix dilates as the presenting fetal part 
descends, thus leading to reorientation of the tissue fibers in the direction 
of the stress. The cervix passively dilates and is pulled over the presenting 
part.   
Evidence also says that the elastin component of the cervix acts like 
a ratchet so that dilatation is maintained even after the contraction caeses.   
In summary, cervical ripening is the realignment of collagen and 
degradation of collagen cross-linking due to proteolytic enzymes. Cervical 
dilation results from these processes along with uterine contractions. In 
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this complicated series of events many changes may occur both 
simultaneously and sequentially.    
ROLE OF THE VARIOUS HORMONES   IN CERVICAL RIPENING   
The hormones stimulate the complex series of chemical reactions 
critical for the process.    
• Dilation of all the tiny vascular channels of the cervix   
• A rise in degradation of collagen   
• Increase in hyaluronic acid   
• A rise in leukocyte, chemotaxis which is the cause for collagen 
degradation   
• And an increase in the release of interleukin (IL)   
The process is associated with an increase in the activity of matrix 
metalloproteinases 2 and 9. Cervical collagenase and elastase also rise. At 
term, the degradation of collagen fibres increases, leading to a decrease in 
collagen content of the cervix.    
Calkins and colleagues were the first to carry out systematic studies 
of the factors influencing the duration of the first stage of labour. The 
authors concluded that the length, thickness, and particularly, the 
consistency of the cervix are important parameters.    
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PROSTAGLANDINS IN LABOUR   
Since their discovery in the early 1970s, prostaglandins (PGs) have 
contributed significantly to the practice of obstetrics. Over the years, many 
PG compounds have been discovered and the importance of the role of 
prostaglandins in several reproductive processes including menstruation, 
ovulation and parturition has become apparent.    
Prostaglandins are important mediators of uterine activity and play 
an important role in the contraction of the smooth muscle of the uterus and 
the biophysical changes associated with cervical ripening. It can be even 
said that prostaglandins seem to play a much larger role in labour than 
oxytocin.   
Almost every tissue in the body produces prostaglandins which 
serve as important messengers in a wide variety of functions. When efforts 
are made to accelerate or inhibit the effects of prostaglandins in labour, we 
also have to deal with their effects on other organs and systems. Attempts 
to decrease the production of prostaglandins in an effort to reduce 
myometrial contractility are limited because of the important role 
prostaglandins play in the maintenance of fetal ductal flow and renal blood 
flow. Likewise, administration of prostaglandins for inducing labour or 
ripening an unfavourable cervix has to be balanced against their effects on 
other systems, including the gastrointestinal tract and brain (O’Brien et al 
1995).   
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The F and E series Prostaglandins are the most important for labour, 
delivery and the postpartum period. In contrast to oxytocin, which requires 
an induction of receptors that does not usually occur until the later part of 
pregnancy, prostaglandin receptors are always present in myometrial 
tissue. Thus the use of prostaglandins remains throughout pregnancy.   
Although both the F and E series Prostaglandins result in uterine 
contractions, the E series of Prostaglandins are relatively more 
uteroselective and are more effective in producing cervical ripening.   
The naturally-occurring prostaglandins were modified to result in 
products that are longer acting and effective at lower concentrations, with 
the potential for significant savings in cost. This has allowed their 
widespread use in developing countries. Problems such as intrauterine 
fetal death and hemorrhage from postpartum uterine atony, which earlier 
required surgical intervention, can be managed with prostaglandins today. 
Currently, all prostaglandins used in clinical practice are synthetic.  
Those like PGE2and PGF2α which retain the molecular structure 
present in nature, are called Natural, while those synthesised with a 
different structure are called analogues.   
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STRUCTURE AND CLASSIFICATION   
Prostaglandins are members of the eicosanoid family. They are 
synthesized from arachidonic acid. Each molecule has 20 carbon atoms 
with a cyclopentane ring and two side chains. The position of the side 
chain and number of multiple bonds determines the group identity and its 
action. Prostaglandins were designated PG1, PG2, PG3, based on the 
number of double bonds in the polyunsaturated fatty acids from which 
they are formed. They were initially divided into classes E and F because 
of their solubility in ether and phosphate buffer. Subsequently, they have  
been divided into ten main groups, A to I. The subscripts (alpha, beta) 
were then added (Van Dorp et al 1964; Bergstrom et al 1964).       
METABOLISM   
Arachidonic acid is metabolised by the enzyme Prostaglandin  
H Synthase (PGHS), formerly called fatty-acid cyclooxygenase. The 
release of arachidonic acid from glyceropholipids in the plasma membrane 
has generally been regarded as being the rate-limiting step in prostaglandin 
biosynthesis (Rice 1995). Prostaglandins act through a number of G-
protein coupled receptors. The final pathways involve intracellular cyclic 
AMP and intracellular calcium. While an increase in intracellular calcium 
is responsible for contraction, increase in cyclic AMP promotes relaxation. 
Thus, by modifying these pathways, PGE2 and PGI2 promote uterine 
quiescence. PGE2 in particular causes cervical ripening. On the other 
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hand, PGF2α causes uterine contractions. Prostaglandin is catabolised by 
the enzyme 15-OH PG dehydrogenase to its metabolites, several of which 
are bioactive. This enzyme is mainly localised in the chorion and prevents 
the prostaglandins from reaching the myometrium in the non-labouring 
state.   
DISTRIBUTION IN NORMAL TISSUES   
PGE2 is the main prostaglandin product of the fetal membranes. 
The inner membrane, the amnion, has the highest production rate (Olson et 
al 1993). PGE2 production by the amnion, chorion, and decidua is 
increased during labour (Olson et al 1993). Though PGE2 and F2α are 
detected in the amniotic fluid in all stages of gestation, the major increase 
occurs with the start of labour, and they continue to increase with 
dilatation of the cervix (MacDonald and Casey 1993). It has been shown 
that prostaglandin concentrations in amniotic fluid increase early in labour 
(<3 cm dilatation) before the active stage of labour is reached (Romero 
1994).    
Properties and clinical effects   
In the same doses, compared to PGF2, PGE2 is 10 times more 
potent on the pregnant uterus (Keirse 1992). Because PGF2α needs to be 
administered in larger doses, it causes more side effects, gastrointestinal in 
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particular. Side effects include nausea, vomiting, diarrhoea, abdominal 
pain, chills and fever. 
Preparations and dosages of prostaglandins currently available                                   
PGE2 
 
 
Vaginal gel 1 and 2 mg 
Endocervical gel 0.5 mg 
Timed-release vaginal insert 3 and 10mg 
PGF2α           IM injection  250/125 mcg 
Misoprostol 
Oral, vaginal, rectal 
administration   
25, 100 and 200 mcg 
 
ROLE OF PROSTAGLANDINS IN LABOUR   
The role of prostaglandins in labour includes softening of the cervix, 
induction of gap junctions (communication between smooth muscle cells 
through which conduction of electrophysiological stimuli occur) and direct 
stimulation of uterine contractions.   
CERVICAL RIPENING   
The first report of the use of prostaglandins in labour was the use of 
PGF2α by Karim et al in 1968. Embrey pioneered the use of PGE2 for 
induction of labour (Embrey 1969) and cervical ripening (Calder and 
Embrey 1971).    
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A number of functional and biochemical changes happen in the 
cervical connective tissue during pregnancy (Leppert 1995). 
Prostaglandins take part in this cervical ripening process, forming a 
complex network of pathways.  
Prostaglandins act synergistically with interleukin-8 to stimulate the 
fibroblasts to produce hyaluronic acid (Ogawa et al 1998), which in turn 
alters the composition and structure of the cervix. Besides this, 
prostaglandins also have an effect on the uterine muscle, inducing 
contractions. Thus, prostaglandins are involved both in cervical ripening 
and subsequently, the process of labour.    
LABOUR   
The process of labour is regulated by endocrine factors such as 
corticotropin-releasing hormone (CRH), oxytocin as well as paracrine and 
autocrine factors and cytokines, such as platelet activating factor, 
endothelin-1 and angiotensin II. Near term, there is a striking increase in 
the number of oxytocin receptors in the myometrium leading to an 
increased sensitivity to oxytocin. Therefore, even a small increase in 
oxytocin is sufficient to initiate uterine contractions. Oxytocin also acts on 
decidual tissue to promote prostaglandin release. At term, free levels of 
CRH increase in maternal blood, fetal blood, amniotic fluid and the 
umbilical cord. CRH modulates myometrial response to PGF2α. CRH also 
enhances the fetal production of cortisol, which stimulates the membranes 
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to increase prostaglandin synthesis. Prostaglandins modulate myometrial 
cell contractility by utilizing extracellular calcium.   
Prostaglandins soften the cervix, induce gap junctions and further 
sensitise the action of oxytocin on the myometrium, causing progressive 
dilatation of the cervix. At the end of the first stage of labour, there is 
rupture of membranes, further increasing prostaglandin synthesis, thus 
making it an irreversible process.     
THE THIRD STAGE OF LABOUR     
After the delivery of the fetus, the uterus remains tonically 
contracted. This helps in separation of the placenta and also prevents 
postpartum hemorrhage.  
There is some evidence that there is considerable production of 
PGF2 in the decidua and the myometrium in the early postpartum period 
after expulsion of the fetus and placenta. (Husslein et al 1983).   
PROSTAGLANDIN E2   
ROUTES OF ADMINISTRATION 
EXTRA-AMNIOTIC   
The effects of prostaglandins on the cervix were initially studied by 
extra-amniotic infusion of prostaglandins. As less invasive and equally 
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effective routes of administration came into use, this route for 
administering prostaglandins has been abandoned.   
ORAL TABLETS   
Oral prostaglandin E2 is no more effective than oxytocin for 
induction of labour but the gastrointestinal side effects, particularly 
vomiting, has been shown to be higher (Keirse and van Oppen 1989).  
This route is no longer used for the induction of labour.   
INTRACERVICAL PGE2   
As gel preparation has been widely used and studied. Its usage for 
cervical ripening is widespread (ACOG 2009).  The gel from is available 
in a 2.5 ml pre-loaded syringe for intracervical application. It contains 0.5 
mg of dinoprostone. With the woman in a dorsolithotomy position, the 
cervix is exposed. The tip of the cannula, which is attached to the prefilled 
syringe, is inserted gently into the internal os. The gel is then instilled into 
the cervix. The patient is kept in a reclining position for the next 30 
minutes. The dose is repeated every 6 hours. A  maximum cumulative 
dose of 1.5 mg of dinoprostone is recommended (three doses or 7.5 ml of 
gel) within a 24-hour period. It is good clinical practice to perform a pelvic 
examination and assess the state of the cervix before the next dose is 
instilled.    
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After inserting the gel, oxytocin infusion should be delayed for   
6-12 hours, because the effect of prostaglandins may be heightened with 
oxytocin (ACOG 2009).   
Intracervical PGE2 gel not only ripens the cervix, but also induces 
labour and reduces the risk of failed induction. About 40 percent of 
women do not need further induction of labour.  
 
A COMPARATIVE  STUDY OF INTRACEVICAL PGE2 WITH 
PLACEBO OR NO TREATMENT   
In a metanalysis (Boulvain et al 2008), it was shown that compared 
to placebo, there was an increased chance of achieving vaginal delivery 
within 24 hours and a small but  statistically insignificant reduction in the 
caesarean section rates when PGE2 was used. The finding was statistically 
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significant in a subgroup of women with intact membranes and 
unfavourable cervix. While there was an increase in hyper stimulation rate, 
there was no significant increase in fetal heart rate changes.   
COMPARISON OF TWO DIFFERENT REGIMENS OF 
PROSTAGLANDIN E2 IN PREINDUCTION  
CERVICAL RIPENING   
Trials were too small to provide data for evidence of effectiveness 
between low and high dose of gels. In a study by Robert et al, a 
randomized clinical study was done to test the relative efficacy of  0.25 mg 
prostaglandin E2 (PGE2), repeated if necessary (group 1) compared to 
0.50 mg PGE2 single dose(group 2) for cervical ripening. In group 1 (42 
patients), the ripening process was repeated every day until spontaneous 
onset of labour occurred or augmentation with oxytocin was decided upon 
(for improved Bishop Score above 5, or maternal or fetal distress). In 
group 2 (42patients) the ones who had not got into labour 12 hours after 
the procedure were induced with oxytocin, irrespective of their cervical 
bishops score. In group 1, 28 patients experienced repeated maturations. 
Thirty patients had an induction of labour with oxytocin in group 2 and 
only 12 in group 1 (P < 0.0001). There were four failures of induction of 
labour in group 2 and none in group 1 (P < 0.05).   
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Three episodes of myometrial hyperstimulation occurred which 
required an emergency  caesarean section for acute fetal distress in group 2 
and none in group 1.  
There were 8 caesarean sections in group 1and 13 in groups 2. The 
outcome of pregnancy was otherwise similar in both groups.  When 
comparing induction of labour using either oxytocin versus PGE2 (vaginal 
or intracervical), induction with PGE2 was associated with (RCOG 2001):  
- Increase in successful vaginal delivery within 24 hours   
- Reduced caesarean section rate    
- Reduced risk of the cervix remaining unfavourable at 24-48 hours 
post induction.   
- Reduced use of epidural analgesia   
- An increase in the number of women satisfied with the method.    
MODIFIED BISHOP’S SCORE AND VAGINAL PH  
PRE-INDUCTION ASSESSMENT 
The goal of labour induction is to achieve a successful vaginal 
delivery, although induction exposes women to a higher risk of a CS than 
spontaneous labour. Before induction, there are several clinical elements 
that need to be considered to estimate the success of induction and 
minimize the risk of CS. Factors that have been shown to influence 
success rates of induction include the Bishop score, parity (prior vaginal 
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delivery), BMI, maternal age, estimated fetal weight, and diabetes. The 
Bishop score was developed in 1964 as a predictor of success for an 
elective induction. The initial scoring system used 5 determinants 
(dilatation, effacement, station, position, and consistency) that attributed a 
value of 0 to 2 or 3 points each (for a maximum score of 13).  
He determined that when the total score was at least 9, the 
likelihood of vaginal delivery following labour induction was similar to 
that observed in patients with spontaneous onset of labour. Although 
several modifications have been suggested, the Bishop score has become a 
classic parameter in obstetrics and has since been applied to a much wider 
group of  patients. Nulliparous women with a Bishop score no greater than 
3 have a 23-fold increased risk of induction failure and a 2- to 4- fold 
increased risk of caesarean delivery compared with nulliparous women 
with a Bishop score of at least 4.   
Similarly, multiparous women with a Bishop score of no greater 
than 3 have a 6-fold increased risk of failed induction and a 2-fold 
increased risk of caesarean birth compared with women with higher 
Bishop scores.  
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BISHOP’S SCORE 
  0 1 2 3 
Dilatation (cm)  0 1-2 3-4 5-6 
Effacement (%)  0-30 40-60 60-70 >80 
Station   -3 -2 -1/0 +1/+2 
Consistency  Firm Medium Soft  
Position  Posterior Mid position Anterior  
 
 
MODIFIED BISHOP’S SCORE (CALDER 1974) 
  0 1 2 3 
Dilatation(cm)  <1 1-2 2-4 >4 
Length (cm)  >4 2-4 1-2 <1 
Station   -3 -2 -1/0 +1/+2 
Consistency  Firm Medium Soft  
Position  Posterior Mid Position 
Anterior 
  
`  
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Other scoring systems  
1. Field system   
2. Burnett modifications of bishops score.   
3. Weighted Bishops score by Freidman.   
4. Pelvic score by Lange  
The Bishop score has become the most commonly employed pre- 
induction scoring system.  
VAGINAL PH 
  In general vagina maintains a pH between 3.8-4.8, which is 
influenced by frequency of coitus, presence of cervical mucus and the 
amount of vaginal transudate. The lactic acid produced from glycogen by 
lactobacillus present in vagina plays an important role in maintaining 
acidic Ph environment. A variety of factors can alter the normal vaginal 
pH. Several factors such as lower genital tract infection; bacterial 
vaginosis, rupture of membrane, douching etc can alter the vaginal pH. 
The acidity of the vagina may alter the release of the drug and this could 
result in variable clinical response. Prostaglandins are organic acids that 
have diminished solubility in aqueous solution with a low pH.  
To summarize, the complex interactions of various cytokines bring 
about profound changes in the proteoglycans in the cervix which 
eventually leads to cervical ripening.  
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Recently, vaginal pH has been investigated as a potential factor 
influencing the efficacy of prostaglandins for cervical ripening and labour 
induction but the results have been conflicting. Studies have been 
conducted on the effects of vaginal pH on the efficacy of controlled-
release PGE2 vaginal insert and PGE2 gel for cervical priming/labour 
induction in which overall vaginal pH seemed to influence the PGE2 
release. 
Nonetheless, the effect of vaginal pH on overall efficacy of the 
cervical ripening/labour induction with PGE2 has not been well studied.  
The vaginal pH in pregnancy is known to be acidic and not much is 
known about the variations in vaginal pH throughout pregnancy. There are 
studies that mention that pH may change the degree of ionization of a drug 
and affect the absorption of the drug resulting in variable clinical 
responses. 
Vaginal pH changes also has a role in preterm delivery which 
suggests that it has a role in influencing cervical ripening. 
The purpose of this study is to evaluate the influence of vaginal pH 
on the efficacy of PGE2 gel for cervical ripening/labour induction which 
would improve patient selection for PGE2 induction and reduce the 
incidence of failed induction with PGE2. 
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PH INDICATOR STRIPS 
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RESULTS AND ANALYSIS 
AGE  
TABLE 1  : AGE DISTRIBUTION OF THE STUDY GROUP 
Age Group in years Frequency Percent 
18-20 27 27.0 
21-25 47 47.0 
26-30 23 23.0 
31-35 3 3.0 
Total 100 100.0 
 
This table shows the age wise distribution of the study group. 
Majority (47 % )of the patients were in the age group of 21 to 25 years. 
The mean age of the study group was 23.49 years 
CHART - 1 
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GESTATIONAL AGE 
TABLE   :  2  GESTATIONAL AGE DISTRIBUTION OF  
THE STUDY GROUP 
GESTATIONAL AGE 
IN WEEKS 
FREQUENCY PERCENT 
UP TO 38 29 29.0 
38-40 25 25.0 
Above 40 46 46.0 
Total 100 100.0 
 
This table depicts the gestational age distribution of the study group. 
About 58 patients were induced at the gestational age of 40 weeks to 40 
weeks 6 days interval. If the NST and AFI monitoring is normal routine 
induction was done at 40 weeks 3 days. 
CHART - 2 
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TABLE : 3 MODIFIED BISHOP'S SCORE DISTRIBUTION IN 
THE STUDY GROUP 
Bishop Score Frequency Percent 
1 7 7.0 
2 32 32.0 
3 43 43.0 
4 17 17.0 
5 1 1.0 
Total 100 100.0 
 
This table shows the distribution of Modified Bishop's Score in the 
study group. 43 patients had a pre-induction Modified Bishop's Score of 3. 
The median Modified Bishop's Score was 3. 
CHART : 3 
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TABLE : 4 
VAGINAL pH DISTRIBUTION AMONG THE STUDY GROUP 
VAGINAL pH Frequency Percent 
4.0 12 12.0 
4.5 28 28.0 
5.0 24 24.0 
5.5 32 32.0 
6.0 4 4.0 
Total 100 100.0 
 
The patients in the study group had vaginal pH in the range of 4 to 
6.60 patients had a vaginal pH of more than 5. The mean vaginal pH in the 
study group was 5. In the study conducted by Ramsey et al the median 
vaginal pH was 5.5 
CHART : 4 
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TABLE : 5 PARITY  
PARITY Frequency Percent 
Primi 63 63.0 
Multi 37 37.0 
Total 100 100.0 
 
CHART : 5 PARITY  
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TABLE – 6 
INDICATION FOR INDUCTION DISTRIBUTION IN THE 
STUDY GROUP 
Indication for 
Induction 
Frequency Percent 
Postdated 53 53.0 
Oligohydramnios 11 11.0 
GHTN 25 25.0 
GDM 9 9.0 
RH Negative 2 2.0 
Total 100 100.0 
 
 The most common indication for induction was postdatism. The 
other two indications were Oligohydramnios and Gestational 
Hypertension complicating pregnancy.  
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INDICATIONS FOR INDUCTION 
Postdated Oligo GHTN GDM RH Negative
 
CHART – 6 : INDICATION FOR INDUCTION DISTRIBUTION IN 
THE  STUDY GROUP 
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TABLE 7 :  PGE2 GEL DOSE DISTRIBUTION IN THE  
STUDY GROUP 
PGE2 GEL DOSE Frequency Percent 
1 95 95.0 
2 5 5.0 
Total 100 100.0 
 
This table  shows  the  number  of  PGE  2  Gel  doses  used  in  the  
study  patients.95  patients  received  a  single  dose  of  PGE  2  gel  and  5  
Patients  received  2  doses  of  PGE  2  gel.  Of  these  5  patients,  1  
delivered  vaginally  and  4  delivered  by  LSCS  for  failed  induction   
CHART  –  7 : PGE2 GEL  DOSE  DISTRIBUTION  IN  THE 
STUDY  GROUP 
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TABLE  8  :  MODE  OF  DELIVERY  DISTRIBUTION   
IN  THE STUDY  GROUP 
Mode  of  Delivery Frequency Percent 
LSCS 44 44.0 
LN  with  EPI 49 49.0 
Outlet  with  EPI 3 3.0 
Vacuum  with  EPI 4 4.0 
Total 100 100.0 
 
This  table  shows  the  distribution  of  mode  of  delivery  in  the  
study  group.  56  patients  had  normal  vaginal  delivery  and  44  patients  
underwent  LSCS.  3  patients  delivered  with  Outlet  forceps  with  
episiotomy  and  4  patients  with  vacuum  with  episiotomy. 
CHART  8  : MODE  OF  DELIVERY  DISTRIBUTION   
IN  THE STUDY  GROUP 
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TABLE  -  9 
INDICATION  FOR  LSCS  DISTRIBUTION 
INDICATION FOR 
LSCS 
Frequency Percent 
Failed  Induction 30 30.0 
Failure  to  progress 6 6.0 
Fetal  Distress 7 7.0 
Imminent  Eclampsia 1 1.0 
Total LSCS 44 44.0 
Normal  Delivery 56 56.0 
Total 100 100.0 
 
Out  of  the  total  100  cases,  44  cases  delivered  by  LSCS.  7  
cases were  done  for  fetal  distress  and  30  cases  for  failed  induction 
CHART  -  9 
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TABLE - 10  : BABY  WEIGHT  IN  KG  DISTRIBUTION  IN  THE 
STUDY GROUP 
Weight  in  Kg Frequency Percent 
Upto  2.5 22 22.0 
2.5-3.0 43 43.0 
3.0-3.5 29 29.0 
Above  3.5 6 6.0 
Total 100 100.0 
 
In  this  study  the  mean  birth  weight  of  the  babies  born  was  
found  to  be  2.9  kg.  About  43  babies  were  in  the  range  of  2.5  to  
3.0  kg 
CHART- 10  :  BABY  WEIGHT  IN  KG  DISTRIBUTION  IN  THE 
STUDY GROUP 
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TABLE 11 : ONE  MINUTE  APGAR  DISTRIBUTION  
IN  THE STUDY  GROUP 
 Frequency Percent 
6 3 3.0 
7 95 95.0 
8 1 1.0 
9 1 1.0 
Total 100 100.0 
 
 In  this  study  95%  of  the  babies  had a 1 minute APGAR of  7. 
CHART  11  : ONE  MINUTE  APGAR  DISTRIBUTION I 
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TABLE  12 :  5  MINUTE  APGAR  DISTRIBUTION   
IN THE  STUDY  GROUP 
5 MIN APGAR Frequency Percent 
7 4 4.0 
8 94 94.0 
9 2 2.0 
Total 100 100.0 
 
In  this  study  94  %  of  the  babies  delivered  had  a  5  minute  
APGAR of  8. 
CHART  12 : 5  MINUTE  APGAR  DISTRIBUTION   
IN THE  STUDY  GROUP 
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TABLE – 13 : INDUCTION DELIVERY INTERVAL 
DISTRIBUTION IN THE STUDY GROUP 
INDUCTION DELIVERY 
INTERVAL 
Frequency Percent 
<6  hours 14 14.0 
6-10  hours 55 55.0 
>10  hours 31 31.0 
Total 100 100.0 
  
 This table shows induction delivery interval in the study group. The 
maximum induction delivery interval is around 6 – 10 hours. The  average  
induction  to  delivery  interval  in  our  study  group  was  9  hours  52  
minutes.   
CHART – 13  : INDUCTION DELIVERY INTERVAL 
DISTRIBUTION IN THE STUDY GROUP 
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TABLE – 15 : TIME  TO  ENTRY  INTO  ACTIVE  PHASE  
 OF  LABOUR  IN  HOURS AMONG OUR STUDY GROUP 
Time taken to enter into 
active phase of labour 
Frequency Percent 
Upto  10 52 52.0 
Above  10 4 4.0 
Total 56 56.0 
 
 This table shows  time  to  entry  into  active  phase  of  labour  in  
hours among our study group. The  average  time  to  entry  into  active  
phase  of  labour     in  our  study  group  was  7 hours  50  minutes 
CHART – 15 
TIME  TAKEN TO ENTER  INTO  ACTIVE  PHASE  OF  LABOUR  
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TABLE  16:  COMPARISON  OF  VAGINAL  pH  AND   
AGE  GROUP  IN  YEARS. 
Vaginal  
pH 
 
 
Age  Group  in  years Total 
 
P  value 
18-20 21-25 26-30 31-35 
4.0 
 
 
Count 6 3 3 0 12 
0.828 
%  within  
Vaginal  pH 
50.0% 25.0% 25.0% .0% 100.0% 
%  within  Age  
Group  in  years 
22.2% 6.4% 13.0% .0% 12.0% 
4.5 
 
 
Count 5 15 7 1 28 
%  within  
Vaginal  pH 
17.9% 53.6% 25.0% 3.6% 100.0% 
%  within  Age  
Group  in  years 
18.5% 31.9% 30.4% 33.3% 28.0% 
5.0 
 
 
Count 8 9 6 1 24 
%  within  
Vaginal  pH 
33.3% 37.5% 25.0% 4.2% 100.0% 
%  within  Age  
Group  in  years 
29.6% 19.1% 26.1% 33.3% 24.0% 
5.5 
   
   
Count 7 18 6 1 32 
%  within  
Vaginal  pH 
21.9% 56.3% 18.8% 3.1% 100.0% 
%  within  Age  
Group  in  years 
25.9% 38.3% 26.1% 33.3% 32.0% 
6.0 
   
   
Count 1 2 1 0 4 
%  within  
Vaginal  pH 
25.0% 50.0% 25.0% .0% 100.0% 
%  within  Age  
Group  in  years 
3.7% 4.3% 4.3% .0% 4.0% 
Total Count 27 47 23 3 100 
%  within  
Vaginal  pH 
27.0% 47.0% 23.0% 3.0% 100.0% 
%  within  Age  
Group  in  years 
100.0% 100.0% 
100.0
% 
100.0% 100.0% 
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 This  table  shows  the  comparison  of  vaginal  pH  and  age  
group  of  the  study  group  patients  which  is  not  statistically  
significant (p value-0.828) 
CHART  :  16 : COMPARISON  OF  VAGINAL  pH  AND   
AGE  GROUP  IN  YEARS. 
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TABLE  17 :  COMPARISON  OF  VAGINAL  pH  AND   
BISHOP  SCORE 
Vaginal  
pH 
 Bishops  score 
P  
value 
     2 6 2 2 
<0.05* 
4.0 Count 16.7% 50.0% 16.7% 16.7% .0% 
   %  within  
Vaginal  pH 
28.6% 18.8% 4.7% 11.8% .0% 
   %  within   
Bishops  
score 
3 11 13 1 0 
4.5 Count 10.7% 39.3% 46.4% 3.6% .0% 
   %  within   
Vaginal  Ph 
     
   %  within   
Bishops  
score 
42.9% 34.4% 30.2% 5.9% .0% 
5.0 Count 2 5 15 2 0 
   %  within   
Vaginal  pH 
8.3% 20.8% 62.5% 8.3% .0% 
   %  within   
Bishops  
score 
28.6% 15.6% 34.9% 11.8% .0% 
5.5 Count 0 9 13 9 1 
   %  within   
Vaginal  pH 
.0% 28.1% 40.6% 28.1% 3.1% 
   %  within   
Bishops  
score 
.0% 28.1% 30.2% 52.9% 100.0% 
6.0 Count 0 1 0 3 0 
   %  within   
Vaginal  pH 
.0% 25.0% .0% 75.0% .0% 
   %  within  
Bishops  
score 
.0% 3.1% .0% 17.6% .0% 
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This  table  shows  the  comparison  of  vaginal  pH  and  mode  of 
delivery  which  is  statistically  significant  (p value-0.019). 76.5  %  of  
patients  with  a  Bishops  score  of  4  delivered vaginally and  23.5%  had  
LSCS.  100  %  of  patients  with  a  Bishops  Score  of  5  delivered  
vaginally only  30  %  of  patients  with  a  Bishops  score  of  3  delivered  
vaginally.  Bishops  score  appears  to  reliably  predict  vaginal  delivery  
only  at  values  of  4  and  above. For  patients  with  a  Bishops  score  of  
3  and  less  than  that  it  was  difficult  to  predict  normal  vaginal  
delivery. 
CHART  :  17 COMPARISON  OF  VAGINAL  pH  AND   
BISHOP  SCORE 
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TABLE  :  18 Vaginal  pH  *  PGE  2 Dose 
Vaginal  
pH 
 PGE  2 Total 
P  
value 
  1 2  
0.273 
4.0 Count 11 1 12 
 %  within   
Vaginal  pH 
91.7% 8.3% 100.0% 
 %  within   
PGE  2 
11.6% 20.0% 12.0% 
4.5 Count 27 1 28 
 %  within   
Vaginal  pH 
96.4% 3.6% 100.0% 
 %  within   
PGE  2 
28.4% 20.0% 28.0% 
5.0 Count 21 3 24 
 %  within   
Vaginal  pH 
87.5% 12.5% 100.0% 
 %  within   
PGE  2 
22.1% 60.0% 24.0% 
5.5 Count 32 0 32 
 %  within   
Vaginal  pH 
100.0% .0% 100.0% 
 %  within   
PGE  2 
33.7% .0% 32.0% 
6.0 Count 4 0 4 
   %  within   
Vaginal  pH 
100.0% .0% 100.0% 
   %  within   
PGE  2 
4.2% .0% 4.0% 
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In  our  study  95  patients  received  a  single  dose  of  PGE  2  gel  
and  5  Patients  received  2  doses  of  PGE  2  gel.  Of  these  5  patients,  
3  delivered  vaginally  and  2  delivered  by  LSCS  for  failed  induction. 
The comparison between vaginal pH and number of times induced by 
PGE2 ( p value-0.273) which is not statistically significant. 
CHART  :  18 Vaginal  pH  *  PGE  2 Dose 
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TABLE  19 :  COMPARISON  OF  VAGINAL  pH AND  MODE  OF  
DELIVERY. 
 Mode  of  Delivery 
 
P Value 
Vaginal  
pH 
 LSCS 
LN 
with 
EPI 
Outlet  
with  EPI 
Vacuum  
with  EPI 
4.0 Count 12 0 0 0 
<0.001** 
 %  within   
Vaginal  pH 
100.0
% 
.0% .0% .0% 
 %  within  Mode   
of  Delivery 
27.3% .0% .0% .0% 
4.5 Count 
19 8 
                                                                                                 
0 
1 
 %  within   
Vaginal  pH 
67.9% 28.6% .0% 3.6% 
 %  within  Mode  of  
Delivery 
43.2% 16.3% .0% 25.0% 
5.0 Count 8 14 0 2 
 %  within   
Vaginal  pH 
33.3% 58.3% .0% 8.3% 
 %  within  Mode   
of  Delivery 
18.2% 28.6% .0% 50.0% 
5.5 Count 5 23 3 1 
 %  within   
Vaginal  pH 
15.6% 71.9% 9.4% 3.1% 
 %  within  Mode   
of  Delivery 
11.4% 46.9% 100.0% 25.0% 
6.0 Count 0 4 0 0 
 %  within  Vaginal  pH .0% 100.0% .0% .0% 
   %  within  Mode  of  
Delivery 
.0% 8.2% .0% .0% 
 Count 44 49 3 4 
%  within  Vaginal  pH 44.0% 49.0% 3.0% 4.0% 
%  within  Mode  of  
Delivery 
100.0
% 
100.0% 100.0% 100.0% 
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This table shows the Comparison of vaginal  pH  and  mode  of  
delivery in the study group  patients  which  is  statistically  significant.  
100% of patients with a vaginal pH of 6 delivered  vaginally.  
83.4% of  patients  with  vaginal pH 5.5, delivered  vaginally  and  15.6% 
underwent LSCS. 67.9% of  patients  with  vaginal  pH  underwent LSCS, 
only  32.1%  delivered vaginally. 100%  of  patients  with  vaginal  pH  of  
4  underwent  LSCS.    
Vaginal  pH  in  the  range  of  5-6  appears  to  predict  vaginal  
delivery  more  reliably  and  it  is  a  better  predictor  of  success  of  
induction. 
Hence this study concludes that higher the vaginal pH higher 
chances of normal delivery when inducing with PGE2 gel.  
(p value <0.001) which is statistically significant. 
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CHART – 19 : :  COMPARISON  OF  VAGINAL  pH AND  MODE  
OF  DELIVERY. 
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TABLE – 20: Vaginal  pH  *  Indication  for  LSCS 
 Vaginal  pH 
Indication  for  LSCS 
Total 
P  value 
 
Failed  
Inducti
on 
Failure  
to  
progress 
Fetal  
Distress 
Immine
nt  
Eclamp
sia 
4.0 Count 11 0 1 0 12 
 
%  within  
Vaginal  pH 
91.7% .0% 8.3% .0% 100.0% 
0.448 
 
%  within  
Indication  
for  LSCS 
36.7% .0% 14.3% .0% 27.3% 
  
4.5 
Count 13 3 2 1 19 
 
%  within  
Vaginal  pH 
68.4% 15.8% 10.5% 5.3% 100.0% 
 
%  within  
Indication  
for  LSCS 
43.3% 50.0% 28.6% 100.0% 43.2% 
  
5.0 
Count 4 2 2 0 8 
 
%  within  
Vaginal  pH 
50.0% 25.0% 25.0% .0% 100.0% 
 
%  within  
Indication  
for  LSCS 
13.3% 33.3% 28.6% .0% 18.2% 
  
5.5 
 
 
 
 
Count 2 1 2 0 5 
 
%  within  
Vaginal  pH 
40.0% 20.0% 40.0% .0% 100.0% 
 
6.7% 16.7% 28.6% .0% 11.4% 
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Vaginal pH
5.55.04.54.0
C
o
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n
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14
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6
4
2
0
Indication for LSCS
Failed Induction
Failure to progress
Fetal Distress
Imminent Eclampsia
6 %  within  
Vaginal  pH 30 6 7 1 44 
% within   
Indication  
for  LSCS 
68.2% 13.6% 15.9% 2.3% 100.0% 
Total 
100.0% 100.0% 100.0% 100.0% 100.0% 
 
 There was no statistical significance between vaginal pH and 
indication for LSCS. (p value > 0.05). Most of the subjects who underwent 
LSCS for failed induction had lower vaginal Ph. 
CHART – 20: : Vaginal  pH  *  Indication  for  LSCS 
 
 
 
 
 
 
 
 
 
  
71 
TABLE – 21: Vaginal  pH  *  Time  Taken to enter into   
Active  Phase  of  Labour  in  hours 
Vaginal  
pH 
 
 
Time taken to enter  
into  Active  Phase  of  
Labour  in  hours Total 
P 
Value 
Upto  10 Above  10 
4.5 Count 8 1 9 
0.909 
 %  within  Vaginal  pH 88.9% 11.1% 100.0% 
 
%  within  Time   taken 
to  enter into  Active  
Phase  of  Labour  in  
hours 
15.4% 25.0% 16.1% 
5.0 Count 15 1 16 
 %  within  Vaginal  pH 93.8% 6.3% 100.0% 
 
%  within  Time   taken 
to  enter into  Active  
Phase  of  Labour  in  
hours 
28.8% 25.0% 28.6% 
5.5 Count 25 2 27 
 %  within  Vaginal  pH 92.6% 7.4% 100.0% 
 
%  within  Time   taken 
to  enter into  Active  
Phase  of  Labour  in  
hours 
48.1% 50.0% 48.2% 
6.0 Count 4 0 4 
 %  within  Vaginal  pH 100.0% .0% 100.0% 
 
%  within  Time   taken 
to  enter into  Active  
Phase  of  Labour  in  
hours 
7.7% .0% 7.1% 
 Count 52 4 56 
 %  within  Vaginal  pH 92.9% 7.1% 100.0% 
 
%  within  Time   taken 
to  enter  into  Active  
Phase  of  Labour  in  
hours 
100.0% 100.0% 100.0% 
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There was no significant association found in vaginal pH 
influencing the time taken to enter active phase of labour.   
(p value > 0.05). 
CHART – 21: Vaginal  pH  *  Time  Taken to enter into   
Active  Phase  of  Labour  in  hours 
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TABLE – 22: Vaginal  pH  *  Parity 
Vaginal  
pH 
 Parity 
Total 
P  value 
  Primi Multi 
4.0 
 
 
Count 10 2 12 
<0.05* 
%  within   
Vaginal  pH 
83.3% 16.7% 100.0% 
%  within  Parity 15.9% 5.4% 12.0% 
4.5 
 
 
Count 19 9 28 
%  within 
  Vaginal  pH 
67.9% 32.1% 100.0% 
%  within  Parity 30.2% 24.3% 28.0% 
5.0 
 
 
Count 17 7 24 
%  within   
Vaginal  pH 
70.8% 29.2% 100.0% 
%  within  Parity 27.0% 18.9% 24.0% 
5.5 
 
 
Count 17 15 32 
%  within   
Vaginal  pH 
53.1% 46.9% 100.0% 
%  within  Parity 27.0% 40.5% 32.0% 
6.0 
 
 
Count 0 4 4 
%  within   
Vaginal  pH 
.0% 100.0% 100.0% 
%  within  Parity .0% 10.8% 4.0% 
Total Count 63 37 100 
%  within   
Vaginal  pH 
63.0% 37.0% 100.0% 
%  within  Parity 100.0% 100.0% 100.0% 
 
 In this observational study there was a significant association 
between vaginal pH and parity (p value – 0.024). Subjects with higher 
parity had a higher vaginal pH (>5). 
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CHART – 22: Vaginal  pH  *  Parity 
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TABLE – 23: Bishop score*Mode of delivery 
Bishops  
score 
 
Mode  of  Delivery 
Total 
P  
value LSCS 
LN  
with  
EPI 
Outlet  
with  
EPI 
Vacuum  
with  
EPI 
1 Count 6 1 0 0 7 
<0.05* 
%  within   
Bishops  score 
85.7% 14.3% .0% .0% 
100.0
% 
%  within  
Mode   
of  Delivery 
13.6% 2.0% .0% .0% 7.0% 
2 Count 21 9 2 0 32 
%  within   
Bishops  score 
65.6% 28.1% 6.3% .0% 
100.0
% 
%  within  
Mode   
of  Delivery 
47.7% 18.4% 66.7% .0% 32.0% 
3 Count 13 26 1 3 43 
%  within   
Bishops  score 
30.2% 60.5% 2.3% 7.0% 
100.0
% 
%  within   
Mode  of  
Delivery 
29.5% 53.1% 33.3% 75.0% 43.0% 
4 Count 4 12 0 1 17 
%  within   
Bishops  score 
23.5% 70.6% .0% 5.9% 
100.0
% 
%  within   
Mode  of   
Delivery 
9.1% 24.5% .0% 25.0% 17.0% 
5 
   
   
Count 0 1 0 0 1 
%  within   
Bishops  score 
.0% 100.0% .0% .0% 
100.0
% 
%  within   
Mode of   
Delivery 
.0% 2.0% .0% .0% 1.0% 
Total Count 44 49 3 4 100 
%  within   
Bishops  score 
44.0% 49.0% 3.0% 4.0% 
100.0
% 
%  within   
Mode   
of  Delivery 
100.0% 100.0% 100.0% 100.0% 
100.0
% 
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 76.5  %  of  patients  with  a  Bishops  score of 4 delivered vaginally 
and  23.5%  had  LSCS.  100 %  of  patients  with  a  Bishops  Score  of 5  
delivered  vaginally. Only  30 %  of  patients  with  a  Bishops  score  of  3  
delivered  vaginally.  Bishops  score  appears  to  reliably  predict  vaginal  
delivery  only  at  values  of  4  and  above  .For  patients  with  a  Bishops  
score  of  3  and  less  than  that  it  was  difficult  to  predict  normal  
vaginal  delivery.  (P value – 0.031) 
CHART – 23: Bishop score*Mode of delivery 
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DISCUSSION 
100 patients  were  included  in  this  study  in  the  age  group  of  
18  to  35  years.  The  mean  age  of  the  study  group  being  23.49  years.  
The  most  common  indication  for  induction  was  postdatism.  The  
other two indications were Oligohydramnios and Gestational  hypertension  
complicating  pregnancy.   
In  a  similar  study  by  Ramsey et  al  the indications for  induction 
were  prolonged  pregnancy, gestational  hypertension,  diabetes  mellitus,  
maternal cholestasis, pruritus, hypothyroidism,  maternal  renal disease, 
suspected fetal growth restriction, oligohydramnios,  polyhydramnios  etc.   
The  patients  in  the  study  group  were  induced  from  37  to  42 
weeks  gestational  age.  About 58 patients were induced at the  gestational  
age of 40 weeks to 40 weeks 6 days interval. If the NST and AFI  
monitoring is normal routine induction was done at 40 weeks 3 days.  In  
the study conducted by Ramsey et al the mean gestational  age at  
induction  was  41  weeks   
The  patients  in  the  study  group  had  a  pre induction Bishop’s  
score  of  1,2.3,4  or  5.32  patients  had  a pre induction Modified  Bishops  
Score  of  3  and 17 patients  had  a pre induction Modified  Bishops  Score  
of  4. The  median. Modified Bishops Score was 3. In  the  study  of  
Ramsey  et  al  also  the  median  Bishops  score  was 3.   
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The  patients  in  the  study  group  had  vaginal  pH  in  the  range  
of   4  to  6.  60  patients  had  a  vaginal  pH  of  more  than  5.5. The  
mean  vaginal  pH  in  the  study  group  was  5. In  the  study  conducted  
by  Ramsey  et  al  the  median  vaginal  pH  was  5.5 
In  our  study  95  patients  received  a  single  dose  of  PGE  2  gel  
and  5  Patients  received  2  doses  of  PGE  2  gel.  Of  these  5  patients,  
3  delivered  vaginally  and  2  delivered  by  LSCS  for  failed  induction.   
On  analyzing  the  mode  of  delivery  in  our  study  56  patients  
had  normal  vaginal  delivery  and  44  patients  underwent  LSCS.  3  
patients  delivered  with  Outlet  forceps,  4  patients  delivered  with  
vacuum.  7  cases  of  LSCS  were  done  for  fetal  distress,  6  cases  for  
failure  to  progress  and  30  cases  for  failed  induction.   
In  this  study  the  mean  birth  weight  of  the  babies  born  was  
found  to  be  2.9  kg.  About  36  babies  were  in  the  range  of  2.5  to  
3.0  kg.   
The  average  induction  to  delivery  interval  in  our  study  group  
was  9  hours  52  minutes.   
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76.5  %  of  patients  with  a  Bishops  score  of  4  delivered 
vaginally and  23.5%  had  LSCS.  100  %  of  patients  with  a  Bishops  
Score  of  5  delivered  vaginally. Only  30  %  of  patients  with  a  
Bishops  score  of  3  delivered  vaginally.  Bishops  score  appears  to  
reliably  predict  vaginal  delivery  only  at  values  of  4  and  above  .For  
patients  with  a  Bishops  score  of  3  and  less  than  that  it  was  difficult  
to  predict  normal  vaginal  delivery.   
The  study  of  Kanwar  et  al  showed  that  73.25  %  cases  with  
Bishop’s  score  >  6  delivered  vaginally  and  26.74%  underwent  LSCS.  
On  the  other  hand  cases  with  Bishop’s  score  of  <  6  had  to  undergo  
LSCS  and  only  20.83  %  delivered  vaginally   
100  %  of  patients  with  a  vaginal  pH  of  6  delivered  vaginally.  
83.4%  of  patients  with  vaginal  pH  of  5.5 delivered  vaginally  and  
15.6%  underwent  LSCS.  67.9%  of  patients  with  vaginal  pH  
underwent  Lscs,  only  32.1%  delivered  vaginally.  100  %  of  patients  
with  vaginal  pH  of  4  underwent  Lscs.  Vaginal  pH  in  the  range  of  
5-6  appears  to  predict  vaginal  delivery  more  reliably  and  it  is  a  
better  predictor  of  success  of  induction.   
According  to  the  study  of  Ramsey  et  al,  vaginally  delivered  
cases  were  more  compared  to  LSCS  when  vaginal  pH  of  more   
than 5. 
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There was no statistically significant association between vaginal 
pH with respect to maternal age, parity, gestational age, time taken to enter 
into active phase of labour and induction delivery interval but there was 
statistically significant difference between vaginal pH of 5 or more with 
initial Bishop score prior to induction and mode of delivery. Normal 
vaginal delivery is considered as successful induction.  
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SUMMARY   
The  present  study  was  done  at  Govt  RSRM  Lying  In  hospital  
to study  vaginal  pH  has  an  effect  on  the efficacy of the  Dinoprostone  
gel  for  cervical  ripening.  Hence  vaginal  pH  as  a  predictor  of  
successful  induction  which  denotes  normal  vaginal  delivery. 
 100 patients were  included  in  this  study  in  the  age  group  of  18  
to  35  years. The  mean  age  of  the  study  group  being  23.49  
years.  The most common indication for induction was postdatism. 
The other two indications were Oligohydramnios and Gestational  
Hypertension  complicating  pregnancy.   
 About 58 patients were induced at the gestational age of  
40  weeks  to  40  weeks  6  days  interval.   
 32 patients had a pre induction Modified Bishops Score of  3. The  
median  Modified  Bishops  Score  was  3.   
 60  patients had a vaginal pH of more than 5.5. The  mean  vaginal  
pH  in  the  study  group  was  5. 
 95 patients received a single dose of PGE2 gel and  
5 Patients  received  2  doses  of  PGE  2  gel.  Of  these 5 patients, 3 
delivered vaginally and 2 delivered by LSCS for failed  induction.   
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 On  analysing the mode of delivery  in  our  study 56 patients  had  
normal vaginal delivery and 44 patients underwent LSCS. 3  patients  
delivered  with  Outlet  forceps,  4 patients  with  vacuum  delivery.  
7  cases  of  LSCS were  done  for  fetal  distress  and  30  cases  for  
failed  induction.   
 In  this  study  the  mean  birth  weight  of  the  babies  born  was  
found  to  be  2.9  kg.  About  36  babies  were  in  the  range  of  2.5  
to  3.0  kg.   
 In  our  study  the  average  induction  delivery  interval  was  9  
hours  and  52  minutes   
 76.5  %  of  patients  with  a  Bishops  score  of  4  delivered 
vaginally and  23.5%  had  LSCS.  100  %  of  patients  with  a  
Bishops  Score  of  5  delivered  vaginally.  Only  30  %  of  patients  
with  a  Bishops  score  of  3  delivered  vaginally.  Bishops  score  
appears  to  reliably  predict  vaginal  delivery  only  at  values  of  4  
and  above  .For  patients  with  a  Bishops  score  of  3  and  less  
than  that  it  was  difficult  to  predict  normal  vaginal  delivery.   
 100  %  of  patients  with  a  vaginal  pH  of  6  delivered  vaginally.  
83.4%  of  patients  with  vaginal  pH  of  5.5 delivered  vaginally  
and  15.6%  underwent  LSCS.  67.9%  of  patients  with  vaginal  
pH  underwent  Lscs,  only  32.1%  delivered  vaginally.  100  %  of  
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patients  with  vaginal  pH  of  4  underwent  Lscs.  Vaginal  pH  in  
the  range  of  5-6  appears  to  predict  vaginal  delivery  more  
reliably  and  it  is  a  better  predictor  of  success  of  induction. 
 Among the previous studies in the literature; there are three studies 
investigating the effect of vaginal pH on efficacy of PGE2 gel and 
the another three investigating the effect of vaginal pH on the 
efficacy of slow-release PGE2 vaginal insert in vivo but giving 
conflicting results.  
 Ramsey et al studies conducted in 2002 and 2003 conflict each 
other. The study in 2002 conducted with PGE2 gel showed 
significant association between higher vaginal pH and the shorter 
time taken to enter into active phase, time to full dilatation and time 
to delivery while the study in 2003 conducted with PGE2 vaginal 
insert showed no significance. The present study also showed no 
significant change in the time to enter active phase of labour.  
 In the present study conducted there was a significant association 
found between the vaginal pH and the Bishop score prior induction 
but the change in the Bishop score over 6-8 hours of induction could 
not be assessed. In the studies conducted by Ramsey et al and 
Basirat et al, there was no significant association found between 
vaginal pH and the initial Bishop score prior induction and the 
change in the Bishop score over 12 hours in contrast to the study 
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conducted by Singh u et al where there was significant association 
found between the vaginal pH and the change in the Bishop score 
over 18 hours which may be due to the difference in the duration (in 
hours) of assessment of Bishop score after an induction. 
 Basirat et al also found that the incidence of Caesarean section was 
lower in women with high vaginal pH as in the present study but 
was not statistically significant. 
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SUMMARY OF COMPARISON OF THE PRESENT STUDY WITH 
PREVIOUS CONDUCTED STUDIES 
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2003 Ramsey et al Insert 34 A A A A 
2008 Onen et al Insert 63 A A A A 
2011 Basirat et al Gel 45 A A A A 
 Present study Gel 100 A A A B 
 
A- Significant association;  B- No significant association 
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CONCLUSION 
Induction  of  labour  is  one  of  the  most  common  obstetric  
practices  carried  out  in  the  world.  Compared  to  spontaneous  onset  of  
labour,  induction  of  labour  is  complicated  by  a  higher  rate  of  
Caesareansection.  This  difference  is  greater  for  nulliparous  women  
with  unfavourable  cervix.   
The pH is important in terms of the design and the efficacy of 
vaginal drug delivery systems.  
To  assess  the  pre  induction  favorability of  the  cervix  vaginal  
pH appears  to  be  better  tool. Vaginal  pH  measurement  is  easy  to  do.   
So this study was conducted  with 100 patients who underwent  
induction  of  labour  at  37  to  40weeks  6  days  in  our  hospital. The 
most common indication  for induction was postdated pregnancy. PGE2 
gel  induction  was  done  and  the  results  were  tabulated  and  analysed. 
Vaginal  pH  in  the  range  of  5  to  6  was  found  to  be a  better  
predictor  of  normal  vaginal  delivery  than  Modified  Bishop’s Score.  
This is a objective,  more  reproducible  and  quantitative method  which  
can be performed easily anywhere. Therefore more liberal  use  of  vaginal  
pH  for  pre induction  cervical  assessment  in  term  pregnancy  would  
enable  obstetricians to predict  the  outcome  of  labour  induction  and  to  
select  a  safe  and  more  efficient  policy  of  induction  
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Hence, findings of the present study suggest that parity influences 
vaginal pH and vaginal pH itself has a significant effect on cervical 
ripening and the Bishop Score prior induction. Higher vaginal pH more 
often responds to a single induction and is more often associated with 
vaginal deliveries than LSCS. 
Hence knowing the vaginal pH prior induction could prove to be a 
useful tool in assessing the labour outcome of a patient undergoing labour 
induction with PGE2 gel. Further research is required to find various 
agents that would increase the vaginal pH thereby creating a favorable 
environment for PGE2 gel induction. 
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4 KRANTHIDEVI 22 633 38W 2 5.5 
G2P1L0 
PREV  NO  
LIVE  CHILD 1 
LN  
WITH  
EPI 
 
3.1 6,7 5  H 
4H 
5 
RASHEEDA  
BEGUM 23 1160 40W5D 3 5.5 
G2P1L1 
POSTDATED 1 
LN  
WITH  
EPI 
 
2.5 8,9 3  H  19  M 
2H 
6 MYTHILI 27 1183 38W5D 3 5.0 
G2P1L1 
GHTN 2 
LN  
WITH  
EPI 
 
3.39 7,8 15  H 
12H 
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7 MANIMEGALAI 26 1226 38W1D 3 4.5 G3P1L0A1 PREV  IUD 2 LN  
WITH  
EPI 
 
3.08 7,8 16  H 9H 
8 VANITHA 26 1262 39W 3 4.5 G2P1L1 GDM  IN  
MEALPLAN 
1 LSCS FAILED  
INDUCT
ION 
3.2 7,8   7  H    
9 AKALYA 22 1330 38W 1 5.0 PRIMI GDM 1 LSCS FAILED  
INDUCT
ION 
2.3 7,8 10  H    
10 PRABAVATHY 25 1373 38W2D 2 5.5 
PRIMI 
GDM 1 LSCS 
FAILED  
INDUCT
ION 
2.10
5 7,8 10  H 
 
11 SANGEETHA 22 1253 38W1D 2 4.5 
SHORT  
PRIMI 
GHTN 1 LSCS 
FAILED  
INDUCT
ION 2.62 7,8 8  H   
 
12 SHANMUGATH
AI 
30 1184 39W 3 5.0 G2P1L1 GHTN 2 LN  
WITH  
EPI 
 
2.52 7,8 12  H   9H 
13 VAIJANTHI 25 1465 40W3D 2 5.5 G3P1L1A1 POSTDATED 1 LN  
WITH  
EPI 
 
3.15 7,8 7  H  50  M 6H 
14 RADHIKA 25 1507 40W 3 5.0 PRIMI POSTDATED 1 LSCS FAILED  3.5 7,8 8H  16  M  
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INDUCT
ION 
15 DIVYA 24 1559 39W 3 5.5 PRIMI OLIGO 1 OUTL
ET  
WITH  
EPI 
 
2.8 7,8 10  H 7H30M 
16 MANJULA 23 1629 37W5D 2 5 PRIMI GHTN 1 LSCS FETAL  
BRADY
CARDIA 
3.2 7,8 7  H   4H 
17 THOOYAMATH 23 1182 37W 1 4.5 G2P1L1 GHTN 1 LSCS FAILED  
INDUCT
ION 
2.8 7,8 8  H  30  M  
18 SHANTHY 23 1176 37W1D 2 5 PRIMI GHTN 2 LSCS FAILED  
INDUCT
ION 
2.5 7,8 13H    
19 DEVI 31 1864 37W 2 5 G2P1L1 OLIGO 1 LN  
WITH  
EPI 
 2.26 7,8 5  H  5  M 4H 
20 PRIYA 21 1765 37W1D 3 4.5 PRIMI OLIGO 1 LSCS IMMINE
NT  
ECLAM
PSIA 
3 7,8   8H  
21 SANDHYA 20 1719 40W2D 2 5.5 PRIMI POSTDATED 1 LN  
WITH  
 
2.9 6,7 12H 10  H 
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EPI 
22 MEENAKSHI 21 1876 40W3D 1 4.5 PRIMI POSTDATED 1 LSCS FAILED  
INDUCT
ION 
3.5 7,8 8H  
23 SUMITHRA 20 1160 40W3D 2 5.5 
PRIMI 
POSTDATED 1 
OUT
LET   
FORC
EPS   
WITH  
EPI 
 
3.4 7,8 13H 
10H30M 
24 BHUVENESH
WARI 
  24 1180 38W 2 4.5 PRIMI GHTN 1 LSCS FAILED  
INDUCTI
ON 
2.8 7,8 8H  
25 NANDHINI 24 1854 39W6D 2   4.5 G2A1 GHTN 1 LN  
WITH  
EPI 
 3.6 7,8 10  H  58  M 9H 
26 ANITHA 23 1856 38W 3 5 PRIMI GHTN 1 LSCS FAILED  
INDUCTI
ON 
2.6 7,8 10H  
27 SANDHYA 26 1936 40W5D 4 5.5 PRIMI POSTDATED 1 LN  
WITH  
EPI 
 2.8 7,8 12H15M 10H 
28 REKHA 25 2056 40W 2 4.5 PRIMI RH  NEG 1 LSCS FETAL  
DISTRES
2.8 7,8 5H  
 S
.N
O
 
N
A
M
E
 
A
G
E
 
IP
.N
O
 
G
A
  
(W
E
E
K
S
) 
B
IS
H
O
P
S
  
S
C
O
R
E
 
V
A
G
IN
A
L
  
P
H
 
O
B
S
T
E
T
R
IC
  
C
O
D
E
 
IN
D
IC
A
T
IO
N
  
F
O
R
 
IN
D
U
C
T
IO
N
 
P
G
E
  
2
 
G
E
L
 D
O
S
E
 
M
O
D
E
  
O
F
  
 
D
E
L
IV
E
R
Y
 
IN
D
IC
A
IO
N
  
F
O
R
  
L
S
C
S
 
B
.W
T
 
A
P
  
G
A
R
 
IN
D
U
C
T
IO
N
 
D
E
L
IV
E
R
Y
 
IN
T
E
R
V
A
L
 
T
IM
E
  
T
A
K
E
N
 T
O
 E
N
T
E
R
  
  
 
IN
  
T
O
  
A
C
T
IV
E
  
P
H
A
S
E
  
O
F
  
L
A
B
O
U
R
 
S 
29 PRABHA 22 1845 40W5D 4 5.5 
PRIMI 
POSTDATED I 
LN  
WITH  
EPI 
 
3 7,8 12H 
9H 
30 KALPANA 27 1926 40W3D 3 4.5 PRIMI POSTDATED 1 LSCS FAILED  
INDUCTI
ON 
2.95 6,7 7H  
31 NALINI 22 1856 40W  6D 4 5 PRIMI POSTDATED 1 LN  
WITH  
EPI 
 3.26 7,8 12  H  15  M 10H 
32 AMBIKA 23 1956 39W 3 4.5 PRIMI OLIGO 1 LN  
WITH  
EPI 
 2.89 7,8 10  H  5  M 8H30M 
33 SUMAYA 26 1958 40W4D 2 4.5 
PRIMI 
POSTDATED 1 LSCS 
FAILED   
INDUCTI
ON 3.1 7,8 7H30M 
 
34 HEMALATHA 29 2034 38W 4 6 G3P2L2 GDM 1 LN  
WITH  
EPI 
 3.25 7,8 5  H  15  M 4H15M 
35 SHANTHI 24 1880 37W 2 4.5 PRIMI OLIGO 1 LSCS FAILED  
INDUCTI
ON 
2.56 7,8 7  H  45  M  
36 NANDHINI 20 1860 40W 3 4.5 PRIMI OLIGO 1 LSCS FAILED  
INDUCTI
2.6 7,8 12H  
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ON 
37 THULASI 27 1880 38W 2 4.5 PRIMI OLIGO 1 LSCS FAILURE  
TO  
PROGRE
SS 
3.2 7,8 16H  
38 PRIYA 33 1170 38W 2 5.5 
G3A2 
POSTDATED 1 LSCS 
FETAL  
DISTRES
S 2.5 7,8 5  H  16  M 
 
39 SURYA 25 1860 40  W4D 3 5.5 PRIMI POSTDATED 1 LN  
WITH  
EPI 
 3.26 7,8 11H  
40 RESHMA 20 1160 40W  4D 2 5.5 PRIMI POSTDATED 1 OUT
LET  
FORC
EPS  
WITH  
EPI 
 2.56 7,8 13  H  6  M 11H 
41 DHIVYA 23 1180 40  W  1  D 2 5.5 
PRIMI 
GHTN 1 LSCS 
FAILED   
INDUCTI
ON 2.2 7,8 6H30M 
 
42 NITHYA 18 1160 40  W  1  D 2 4.5 PRIMI POSTDATED 1 LN  
WITH  
EPI 
 3.6 7,8 12H 9H48M 
43 KEERTHANA 23 1264 40  W  5D 2 4 PRIMI POSTDATED 1 LSCS FAILED  3.6 7,8 8  H  
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INDUCTI
ON 
44 ABITHA 20 1987 37  W  5D 1  4 PRIMI PREECLAMPSIA 1 LSCS FAILED  
INDUCTI
ON 
1.3 7,8 8  H  
45 MUNIYAMM
AL 
24 2624 40  W3D 4 5.5 G2P1L1 POSTDATED 1 LSCS FETAL  
DISTRES
S 
2.7 7,8 6H  17  M  
46 AMIRTHAVA
LLI 
26 2965 40  W   2 4.5 PRIMI POSTDATED 1 LSCS FAILED  
INDUCTI
ON 
2.8 7,8 7H35  M  
47 DEEPIKA 22 1265 37W 1 4.5 PRIMI   GHTN 1  
LSCS 
MSAF/FE
TAL  
DISTRES
S 
2.5 7,8  4H  50M  
48 DIVYABHAR
ATHI 
21 5356 39W  2D 3 5.5 PRIMI PROM 1 LN  
WITH  
EPI 
 2.8 7,8 8  H  30  M 6H 
49 PAVITHRA 18 5288 40  W  3D 4 5.5 PRIMI POSTDATED 1 LN  
WITH  
E87PI 
 2.89 7,8 8H 6H 
50 GOMATHY 21 5142 40  W  6D   1 4 
 
 1 LSCS 
FETAL  
DISTRES
S   2.6 7,8   2H  40M 
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51 VASANTHI 26 5312 40  W  1D 3 5.5 G2A1 POSTDATED 1 LN  
WITH  
EPI 
   2.5 7,8 11H  50M 9H 
56 KEERTHI 2
8 
4
8
6
2 
40W2D 2 4 PRIMI POSTDATED 1 L
S
C
S 
FAIL
ED  
IND
UCTI
ON 
2.9 7,8 8  H  
57 GOWTHAMI 2
8 
4
5
6
2 
38W 3 5 PRIMI  GHTN 1 V
A
C
C
U
M
  
W
I
T
H
  
E
P
I 
 2.08 7,8 8H  
10M 
6
H 
58 GAYATHR 2640W  3D 3 5.5 G3P2L2 POSTDATED 1 L  3.4 7,8 3H  1
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3
0
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59 AKILA 2
0 
6
7
9
8 
38W 3 5 PRIMI  GHTN 1 L
N
  
W
I
T
H
  
E
P
I 
 2.8 7,8 8  H  
30  M 
6
H 
60 PARVEEN 5
5 
6
8
7
38W 2 4 PRIMI GHTN 1 L
S
C
FAIL
URE 
TO 
2.9 7,8 12H    
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61 GEETHA  
PRASANAKUMAR 
2
7 
6
9
8
9 
38W 3 5 PRIMI GHTN 1 V
A
C
C
U
M
  
W
I
T
H
  
E
P
I 
 3 7,8  12H  
33M 
6
H 
62 NEELA 1
9 
7
4
0
6 
40  W  2D 3 4.5 PRIMI  POSTDATED 1 L
N
  
W
I
T
 2.7 7,8 10H 6
H 
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63 SYED  MEENA 1
9 
7
4
1
5 
40  W 4 5 PRIMI GHTN  
POSTDATED 
1 L
N
  
W
I
T
H
  
E
P
I 
 3.1 7,8 9H  
55M 
6
H 
64 JANSI 2
4 
7
4
3
8 
40  W  6D 3 5.5 G3P2L2 POSTDATED 1 L
N
  
W
I
T
H
  
 2.9 7,8 5H  
55M 
4
H 
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65 DESARANI 2
8 
7
4
9
7 
40  W   3 4 PRIMI POSTDATED 1  
L
S
C
S 
 
FAIL
EDIN
DUC
TION 
2.8 7,8 8H  
66 GNANASUDA 2
9 
7
4
9
8 
39W6D 3 5.5 G3P1L1A1  OLIGO 1 L
N
  
W
I
T
H
  
E
P
I 
 3.025 7,8 10H  
20M 
7
H 
67 KAVITHA 2
2 
7
5
1
9 
40  W   4 6 G2P1L1 POSTDATED 1 L
N
  
W
I
 2.3 7,8 4H  
30M 
2
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68 JEBENA 2
0 
7
4
6
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40  W  2D 3 4.5 PRIMI POSTDATED 1 L
S
C
S 
CPD  
IN  
LAB
OUR 
  3.02 7,8 8  H  
15M 
 
69 ARCHANA 2
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40  W  3D   4 4 PRIMI POSTDATED 1  
L
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C
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FAIL
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IND
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2.9 7,8 8H  
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71 ESWARI 
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1
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1
2
6 40W1D 4 6 
G3P2L2 
POSTDATED 1 
L
N
  
W
I
T
H
  
E
P
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4
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0
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FET
AL  
DIST
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3.2 7,8 10H 
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1
1
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2
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1
0
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3 40W  1D 2 4 
PRIMI 
POSTDATED 1 
 
L
S
C
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FAIL
ED  
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ON 3.00 7,8 8H 
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79 HEMALATHA 
2
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1
0
4
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5 39W 3  4.5 
PRIMI 
GHTN 1 
L
S
C
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FAIL
ED  
IND
UCTI
ON 2.5 7,8 14H 
 
80 
MUTHULAKSH
MI 19 10500 38W   3 5 
PRIMI 
GDM 1 
LN  WITH  
EPI 
 
2.1 7,8 12H 
9
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81 PAVITHRAA 20 10417 
40W  
2D 2 4 
 
  PRIMI POSTDATED 1 LSCS 
FAILED  
INDUCTION 2.5 7,8  8H 
 
82 GAYATHRI 25 10537 
40W  
4D  2 5 
 
PRIMI 
POSTDATED 1 LSCS 
FAILURE  
TO  
PROGRESS 2.8 7,8 10H 
 
83 DIVYA 22 10511 
40  
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2D 3 4.5 
PRIMI 
POSTDATED 1 LSCS 
FAILED  
INDUCTION 
3.0 7,8 8H 
 
84 KOWSALYA 20 19601 
40  
W  
2D   3 4 
 
PRIMI 
POSTDATED 2 LSCS   
FAILED  
INDUCTION 
2.8 7,8 14H 
 
85 
HASEENA  
BEGAM 27 10609 
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G2P1L1 POSTDATED 1 LSCS   
FAILURE  
TO  3.6 7,8 12H 
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D PROGRESS 
86 THENMOZHI 20 9438 
40  
W  
2D 4 5.5 
 
PRIMI 
POSTDATED 1 VACCUM 
 
2.6 7,8 10H 
8
H
  
3
0
M 
87 AARTHI 19 9253 38W 3 5 
 
PRIMI 
GTHN 1 
LN  WITH  
EPI 
 
3.1 7,8 12H 
9
H
  
3
0
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88 NANDHINI 19 9461 
40W  
3D 3 5.5 
 
PRIMI 
POSTDATED 1 
LN  WITH  
EPI 
 
3 7,8   8H 
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40  
W  
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I W  
2D 
PRIMI INDUCTION 
91 NIRMALA 25 9582 37W 3 5.5 
 
G2P1L1 GDM  ON  
INSULIN 1 
LN  WITH  
EPI 
 
3.3 7,8 8H 
 
6
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92 SHARMILA 21 9485 
40  
W  
2D 3 4.5 
 
G2P1L1 
POSTDATED 1 
LN  WITH  
EPI 
 
2.9 7,8 10H  30M 
 
8
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93 ANUSIYA 22 9881 
40  
W  
1D 3 5 
 
G2A1 
POSTDATED 1 
LN  WITH  
EPI 
 
3.1 7,8 8H  30M 
 
7
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94 POONGODI 26 9203 
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W 3  5 
 
PRIMI 
GDM 1 LSCS 
FAILURE  
TO  
PROGRESS 3.1 7,8 11  H  6  M 
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40  
W  
3D 3 5.5 
 
PRIMI 
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97 RUBINI 25 9510 
38W  
3D    3 5.5 
 
PRIMI 
OLIGO 1 
LN  WITH  
EPI 
 
2.3 7,8 6H  30M 
 
5
H 
98 AALIYA 23 9673 
40  
W   4 4 
 
 
PRIMI RH  NEG 1 LSCS 
FAILED  
INDUCTION 
3.6 7,8 7H   
 
99 INDUMATHY 27 9532 
40  
W  5  
D 4 5.5 
 
PRIMI 
POSTDATED 1 
LN  WITH  
EPI 
 
2.89 7,8 7  H  18  M 
 
5
H
  
4
5
M 
100 AARTHI 29 9158 
40  
W  4  
D 3 5 
 
G2P1L1 
 
POSTDATED 1 
LN  WITH  
EPI 
 
3.12 7,8 6  H  43  M 
 
5
H
4
5
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